Marks Gilbert Lynn 4
4 · AN2 Therapeutics, Inc. · Filed Jan 14, 2026
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Common Stock
[F1]2026-01-12+11,560→ 75,309 total
Footnotes (1)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks|2026-01-14